Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1117 studies found for:    "Retinoschisis" OR "Retinal Degeneration" OR "X-linked juvenile retinoschisis"
Show Display Options
Rank Status Study
21 Active, not recruiting Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Conditions: Macular Degeneration;   Age-Related Maculopathies;   Age-Related Maculopathy;   Maculopathies, Age-Related;   Maculopathy, Age-Related;   Retinal Degeneration;   Retinal Neovascularization;   Gene Therapy;   Therapy, Gene;   Eye Diseases
Intervention: Biological: AAV2-sFLT01
22 Completed Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
Conditions: Age-Related Maculopathy;   Age-Related Maculopathies;   Eye Diseases;   Retinal Degeneration;   Macular Degeneration
Interventions: Biological: RN6G;   Biological: Placebo
23 Completed Clinical and Pathophysiological Description of Ocular Ischemic Syndrome
Conditions: Retinal Degeneration;   Diabetic Retinopathy
Intervention:
24 Active, not recruiting Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Retinal Diseases;   Eye Diseases;   Eye Disease, Hereditary;   Retinal Degeneration
Intervention: Drug: Valproic Acid
25 Enrolling by invitation Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinal Degeneration,;   Retinitis Pigmentosa
Intervention: Procedure: surgical implantation of subretinal device
26 Recruiting Argus® II Retinal Prosthesis System Post-Market Surveillance Study
Conditions: Outer Retinal Degeneration;   Retinitis Pigmentosa
Intervention:
27 Recruiting Retinal Imaging in Patients With Inherited Retinal Degenerations
Condition: Retinitis Pigmentosa
Intervention:
28 Terminated A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Conditions: Age Related Macular Degeneration;   Choroidal Neovascular Membrane;   Subfoveal Neovascular Age-Related Macular Degeneration;   Macular Degeneration;   Wet Age-Related Macular Degeneration
Intervention: Drug: Ranibizumab
29 Recruiting Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)
Conditions: Stargardt's Macular Dystrophy;   Fundus Flavimaculatus;   Juvenile Macular Dystrophy
Intervention: Biological: MA09-hRPE
30 Recruiting A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies
Condition: Stargardt Disease
Intervention:
31 Completed Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Drug: ranibizumab, dexamethasone and verteporfin;   Drug: Ranibizumab
32 Recruiting Repository for Inherited Eye Diseases
Conditions: Retinitis Pigmentosa;   Inherited Ophthalmic Diseases
Intervention:
33 Unknown  Long-Term Efficacy in AMD of Rheopheresis in North America
Condition: Macular Degeneration
Intervention: Device: Rheopheresis blood filtration
34 Recruiting High Resolution Retinal Imaging
Conditions: Stargardts;   Retinitis Pigmentosa;   Age-related Macular Degeneration;   Choroideremia;   Geographic Atrophy
Intervention: Procedure: Retinal imaging
35 Unknown  Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System
Conditions: Macular Degeneration;   Choroidal Neovascularization
Intervention: Device: Ocular Brachytherapy
36 Active, not recruiting Argus® II Retinal Stimulation System Feasibility Protocol
Condition: Retinitis Pigmentosa
Intervention: Device: Argus II Retinal Stimulation System
37 Completed
Has Results
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
Condition: Retinitis Pigmentosa
Interventions: Drug: Lutein;   Dietary Supplement: Cornstarch control
38 Completed Pain Perception at Laser Treatment
Condition: Laser Therapy, Low-Level
Intervention: Procedure: retina photocoagulation
39 Completed
Has Results
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Procedure: Standard of Care Group;   Drug: 1mg triamcinolone acetonide;   Drug: 4mg triamcinolone acetonide
40 Completed Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)
Condition: Macular Degeneration
Intervention: Drug: rhuFab V2 (ranibizumab)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years